ICH Management Andrew M. Demchuk MD FRCPC Director, Calgary Stroke - - PowerPoint PPT Presentation

ich management
SMART_READER_LITE
LIVE PREVIEW

ICH Management Andrew M. Demchuk MD FRCPC Director, Calgary Stroke - - PowerPoint PPT Presentation

ICH Management Andrew M. Demchuk MD FRCPC Director, Calgary Stroke Program Pillar 2 Chair APSS (Acute Care and Emergency Services) Heart and Stroke Foundation Chair in Stroke Research Professor University of Calgary Epidemiology of ICH


slide-1
SLIDE 1

ICH Management

Andrew M. Demchuk MD FRCPC Director, Calgary Stroke Program Pillar 2 Chair APSS (Acute Care and Emergency Services) Heart and Stroke Foundation Chair in Stroke Research Professor University of Calgary

slide-2
SLIDE 2

Epidemiology of ICH

Comprises 15% 10% of stroke in the NA/Europe 30% in the developing world 6 month prognosis 40% dead 40% disabled and dependent 20% independent

slide-3
SLIDE 3

Mechanism - ICH

Hypertension

฀ Treat the hypertension – may NOT be

necessary acutely

Drugs (eg. PPA, cocaine)

฀ Lifestyle changes

Amyloid angiopathy

฀ No treatment

AVM

฀ Surgery, radiosurgery, embolization

slide-4
SLIDE 4

Investigation of ICH for underlying etiology

Noncontrast CT +/- CT-angiography MRI with GRE/SWI Conventional angiography

Hypertension Amyloid angiopathy Arteriovenous malformation Intracranial aneurysm Cavernous angioma Dural venous sinus thrombosis Intracranial neoplasm Coagulopathy Cocaine or alcohol use

slide-5
SLIDE 5

Severe Amyloid Angiopathy Pattern

Gradient echo imaging

slide-6
SLIDE 6

Hypertensive Arteriolosclerosis Pattern

Gradient echo imaging

slide-7
SLIDE 7

Acute CT for prognosis: ICH Volume Measurement, IVH, location

A x B x C / 2 A – greatest width B – greatest length C – depth

slide-8
SLIDE 8

Prognosis

  • Size and location of hematoma
  • Presence of IVH
  • Clinical deficit
slide-9
SLIDE 9

2.5 hours after symptom onset

6.5 hours after onset, with enlargement of the hematoma due to ongoing bleeding

“Early Hematoma Growth”

slide-10
SLIDE 10
slide-11
SLIDE 11

Dripping with each passing minute

slide-12
SLIDE 12

Case 1

  • 48 year old hypertensive
  • Onset 2 hours ago
  • Right hemiplegia
  • Basal ganglia ICH 20 ml
  • Systolic BP 210
slide-13
SLIDE 13
slide-14
SLIDE 14

<150 systolic BP lowering marginal in ICH

slide-15
SLIDE 15
slide-16
SLIDE 16

More aggressive BP lowering in ICH no effect

slide-17
SLIDE 17
slide-18
SLIDE 18

ICH Management

Comprehensive stroke centre if severe deficits? BP <140 mmHg systolic but not much lower best

slide-19
SLIDE 19

Case 2

  • 78 year old afib on warfarin
  • Subcortical ICH 6 ml
  • Systolic BP 140
slide-20
SLIDE 20

Anticoagulation major risk for hematoma expansion

slide-21
SLIDE 21

Prothrombin Complex Concentrate for Coagulopathy

Clotting factors: FII, VII, IX and X, protein C and S.

slide-22
SLIDE 22
slide-23
SLIDE 23

Prothrombin Complex Concentrate for Coagulopathy

1000U INR 1.5-3 2000U if INR 3-5 3000U if INR >5

slide-24
SLIDE 24

Praxbind bolus for Dabigatran associated ICH

slide-25
SLIDE 25

ICH Management

Urine toxicology screen

CT/CTA should be standard INR STAT crucial

slide-26
SLIDE 26

Our Imaging in ICH Philosophy:

Good Quality Plain CT and mCTA brain to view for abnormal arteries/veins and view the leakpoint! Don’t Leave the ED Without It!

slide-27
SLIDE 27
slide-28
SLIDE 28

Spot Sign Contrast Extravasation

slide-29
SLIDE 29

rFVIIa ICH Trials Failed

slide-30
SLIDE 30

Logarithmic curve of bleeding with increasing hemostasis then contraction

time ICH volume

slide-31
SLIDE 31

Logarithmic curve of bleeding with increasing hemostasis then contraction

time ICH volume

slide-32
SLIDE 32

Future Directions

  • Hemostasis needs to be initiated much earlier
  • Spot sign predicts HE but needs refinement
  • Hemostatic ICH trial design should focus on:
  • ultraearly time windows (<2h)
  • Deferral or waiver of consent
  • pre-hospital setting (CT ambulance)
slide-33
SLIDE 33

Emerging acute tx of ICH

Hematoma expansion prevention therapy Surgical evacuation of ICH Thrombolysis in IVH

slide-34
SLIDE 34

ICH Surgical Decision Making?

D E

slide-35
SLIDE 35

When to Operate?

slide-36
SLIDE 36

Hanley D et al. ISC 2012

slide-37
SLIDE 37
slide-38
SLIDE 38
slide-39
SLIDE 39

Intraventricular Hemorrhage

slide-40
SLIDE 40

tPA instillation 1 mg q8h dual vent drains

CLEAR IVH Phase 3 trial

slide-41
SLIDE 41

41

Most ICHs Should Be Care For At CSCs

IV TPA Delivery Tertiary Care (Telestroke, Transfers, Education, etc.) Comprehensive Stroke Centre Primary Stroke Centre Proposed Primary Stroke Centre

Calgary Zone

1,326,115

Calgary serves as the only comprehensive care centre in the south and the primary care centre for an area with over 1.3 million residents (2009)

slide-42
SLIDE 42

Key Messages

  • ICH 2nd most common stroke
  • BP control to systolic ~140 mmHg quickly
  • Correction of coagulopathy needed STAT
  • Bleeding occurs very early which has

limited development of hemostatic tx.

  • Surgery offered in moderate sized cerebral
  • r large cerebellar ICH
  • Minimally invasive surgery promising
slide-43
SLIDE 43

Thank You for your attention